Palvella Therapeutics PVLA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's total liabilities?
- Palvella Therapeutics (PVLA) reported total liabilities of $31.45M in Q1 2026.
- How has Palvella Therapeutics's total liabilities changed year-over-year?
- Palvella Therapeutics's total liabilities increased by 31.8% year-over-year, from $23.86M to $31.45M.
- What is the long-term trend for Palvella Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Palvella Therapeutics's total liabilities has grown at a -15.7% compound annual growth rate (CAGR), from $73.98M to $31.58M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.